Monte Rosa announced clinical results from its MRT-6160 Phase 1, single ascending dose / multiple ascending dose study. Details about the study, First-in-human Study of MRT-6160 in Healthy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback